Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Related structures:
AlphaFold database: Q4Q4L9
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 38 | 42 | PF00656 | 0.387 |
CLV_C14_Caspase3-7 | 516 | 520 | PF00656 | 0.572 |
CLV_C14_Caspase3-7 | 68 | 72 | PF00656 | 0.518 |
CLV_NRD_NRD_1 | 339 | 341 | PF00675 | 0.643 |
CLV_NRD_NRD_1 | 412 | 414 | PF00675 | 0.710 |
CLV_NRD_NRD_1 | 88 | 90 | PF00675 | 0.553 |
CLV_PCSK_KEX2_1 | 338 | 340 | PF00082 | 0.655 |
CLV_PCSK_KEX2_1 | 412 | 414 | PF00082 | 0.663 |
CLV_PCSK_KEX2_1 | 88 | 90 | PF00082 | 0.553 |
CLV_PCSK_SKI1_1 | 18 | 22 | PF00082 | 0.434 |
CLV_PCSK_SKI1_1 | 217 | 221 | PF00082 | 0.506 |
CLV_PCSK_SKI1_1 | 307 | 311 | PF00082 | 0.636 |
CLV_PCSK_SKI1_1 | 451 | 455 | PF00082 | 0.504 |
CLV_PCSK_SKI1_1 | 89 | 93 | PF00082 | 0.483 |
DEG_APCC_DBOX_1 | 17 | 25 | PF00400 | 0.475 |
DEG_APCC_DBOX_1 | 216 | 224 | PF00400 | 0.474 |
DEG_Nend_UBRbox_1 | 1 | 4 | PF02207 | 0.668 |
DEG_SPOP_SBC_1 | 319 | 323 | PF00917 | 0.521 |
DEG_SPOP_SBC_1 | 359 | 363 | PF00917 | 0.607 |
DEG_SPOP_SBC_1 | 36 | 40 | PF00917 | 0.375 |
DOC_CKS1_1 | 452 | 457 | PF01111 | 0.405 |
DOC_CYCLIN_RxL_1 | 112 | 121 | PF00134 | 0.382 |
DOC_CYCLIN_RxL_1 | 213 | 224 | PF00134 | 0.509 |
DOC_PP1_RVXF_1 | 114 | 121 | PF00149 | 0.358 |
DOC_PP4_FxxP_1 | 452 | 455 | PF00568 | 0.486 |
DOC_USP7_MATH_1 | 132 | 136 | PF00917 | 0.484 |
DOC_USP7_MATH_1 | 139 | 143 | PF00917 | 0.606 |
DOC_USP7_MATH_1 | 159 | 163 | PF00917 | 0.483 |
DOC_USP7_MATH_1 | 253 | 257 | PF00917 | 0.706 |
DOC_USP7_MATH_1 | 268 | 272 | PF00917 | 0.695 |
DOC_USP7_MATH_1 | 319 | 323 | PF00917 | 0.588 |
DOC_USP7_MATH_1 | 359 | 363 | PF00917 | 0.607 |
DOC_USP7_MATH_1 | 486 | 490 | PF00917 | 0.392 |
DOC_WW_Pin1_4 | 147 | 152 | PF00397 | 0.606 |
DOC_WW_Pin1_4 | 297 | 302 | PF00397 | 0.593 |
DOC_WW_Pin1_4 | 315 | 320 | PF00397 | 0.699 |
DOC_WW_Pin1_4 | 390 | 395 | PF00397 | 0.653 |
DOC_WW_Pin1_4 | 451 | 456 | PF00397 | 0.407 |
DOC_WW_Pin1_4 | 49 | 54 | PF00397 | 0.383 |
LIG_14-3-3_CanoR_1 | 11 | 20 | PF00244 | 0.457 |
LIG_14-3-3_CanoR_1 | 338 | 345 | PF00244 | 0.626 |
LIG_14-3-3_CanoR_1 | 375 | 379 | PF00244 | 0.545 |
LIG_14-3-3_CanoR_1 | 76 | 85 | PF00244 | 0.469 |
LIG_14-3-3_CanoR_1 | 88 | 94 | PF00244 | 0.572 |
LIG_Actin_WH2_2 | 457 | 475 | PF00022 | 0.452 |
LIG_BIR_III_4 | 121 | 125 | PF00653 | 0.411 |
LIG_BIR_III_4 | 510 | 514 | PF00653 | 0.480 |
LIG_BRCT_BRCA1_1 | 141 | 145 | PF00533 | 0.623 |
LIG_BRCT_BRCA1_1 | 51 | 55 | PF00533 | 0.434 |
LIG_FHA_1 | 148 | 154 | PF00498 | 0.573 |
LIG_FHA_1 | 194 | 200 | PF00498 | 0.395 |
LIG_FHA_1 | 339 | 345 | PF00498 | 0.693 |
LIG_FHA_1 | 444 | 450 | PF00498 | 0.558 |
LIG_FHA_2 | 124 | 130 | PF00498 | 0.613 |
LIG_FHA_2 | 438 | 444 | PF00498 | 0.601 |
LIG_FHA_2 | 483 | 489 | PF00498 | 0.536 |
LIG_FHA_2 | 514 | 520 | PF00498 | 0.651 |
LIG_FHA_2 | 55 | 61 | PF00498 | 0.610 |
LIG_FHA_2 | 66 | 72 | PF00498 | 0.357 |
LIG_HCF-1_HBM_1 | 200 | 203 | PF13415 | 0.498 |
LIG_LIR_Apic_2 | 450 | 455 | PF02991 | 0.487 |
LIG_LIR_Gen_1 | 117 | 125 | PF02991 | 0.397 |
LIG_LIR_Gen_1 | 393 | 400 | PF02991 | 0.491 |
LIG_LIR_Nem_3 | 14 | 20 | PF02991 | 0.424 |
LIG_LIR_Nem_3 | 393 | 399 | PF02991 | 0.484 |
LIG_Pex14_2 | 295 | 299 | PF04695 | 0.529 |
LIG_Pex14_2 | 51 | 55 | PF04695 | 0.344 |
LIG_SH2_SRC | 31 | 34 | PF00017 | 0.436 |
LIG_SH2_STAT5 | 245 | 248 | PF00017 | 0.536 |
LIG_SH2_STAT5 | 448 | 451 | PF00017 | 0.472 |
LIG_SH2_STAT5 | 483 | 486 | PF00017 | 0.419 |
LIG_SH2_STAT5 | 77 | 80 | PF00017 | 0.428 |
LIG_SH2_STAT5 | 85 | 88 | PF00017 | 0.461 |
LIG_SH3_3 | 206 | 212 | PF00018 | 0.440 |
LIG_SH3_3 | 30 | 36 | PF00018 | 0.532 |
LIG_SH3_3 | 417 | 423 | PF00018 | 0.575 |
LIG_TRAF2_1 | 126 | 129 | PF00917 | 0.554 |
LIG_TRAF2_1 | 371 | 374 | PF00917 | 0.657 |
MOD_CDK_SPxxK_3 | 147 | 154 | PF00069 | 0.547 |
MOD_CDK_SPxxK_3 | 451 | 458 | PF00069 | 0.401 |
MOD_CK1_1 | 135 | 141 | PF00069 | 0.691 |
MOD_CK1_1 | 256 | 262 | PF00069 | 0.665 |
MOD_CK1_1 | 318 | 324 | PF00069 | 0.703 |
MOD_CK1_1 | 392 | 398 | PF00069 | 0.605 |
MOD_CK1_1 | 44 | 50 | PF00069 | 0.517 |
MOD_CK2_1 | 123 | 129 | PF00069 | 0.610 |
MOD_CK2_1 | 281 | 287 | PF00069 | 0.572 |
MOD_CK2_1 | 368 | 374 | PF00069 | 0.664 |
MOD_CK2_1 | 400 | 406 | PF00069 | 0.581 |
MOD_CK2_1 | 437 | 443 | PF00069 | 0.516 |
MOD_CK2_1 | 482 | 488 | PF00069 | 0.493 |
MOD_GlcNHglycan | 13 | 16 | PF01048 | 0.351 |
MOD_GlcNHglycan | 136 | 140 | PF01048 | 0.592 |
MOD_GlcNHglycan | 172 | 175 | PF01048 | 0.429 |
MOD_GlcNHglycan | 257 | 261 | PF01048 | 0.707 |
MOD_GlcNHglycan | 325 | 328 | PF01048 | 0.638 |
MOD_GlcNHglycan | 370 | 373 | PF01048 | 0.620 |
MOD_GlcNHglycan | 46 | 49 | PF01048 | 0.482 |
MOD_GlcNHglycan | 488 | 491 | PF01048 | 0.396 |
MOD_GlcNHglycan | 79 | 82 | PF01048 | 0.512 |
MOD_GSK3_1 | 131 | 138 | PF00069 | 0.683 |
MOD_GSK3_1 | 239 | 246 | PF00069 | 0.519 |
MOD_GSK3_1 | 256 | 263 | PF00069 | 0.531 |
MOD_GSK3_1 | 297 | 304 | PF00069 | 0.630 |
MOD_GSK3_1 | 315 | 322 | PF00069 | 0.618 |
MOD_GSK3_1 | 35 | 42 | PF00069 | 0.563 |
MOD_GSK3_1 | 359 | 366 | PF00069 | 0.729 |
MOD_GSK3_1 | 477 | 484 | PF00069 | 0.455 |
MOD_GSK3_1 | 486 | 493 | PF00069 | 0.414 |
MOD_GSK3_1 | 49 | 56 | PF00069 | 0.326 |
MOD_GSK3_1 | 7 | 14 | PF00069 | 0.450 |
MOD_GSK3_1 | 92 | 99 | PF00069 | 0.472 |
MOD_NEK2_1 | 320 | 325 | PF00069 | 0.559 |
MOD_NEK2_1 | 43 | 48 | PF00069 | 0.550 |
MOD_NEK2_1 | 460 | 465 | PF00069 | 0.438 |
MOD_NEK2_1 | 54 | 59 | PF00069 | 0.435 |
MOD_NEK2_1 | 7 | 12 | PF00069 | 0.572 |
MOD_NEK2_2 | 139 | 144 | PF00069 | 0.459 |
MOD_PIKK_1 | 152 | 158 | PF00454 | 0.523 |
MOD_PIKK_1 | 338 | 344 | PF00454 | 0.673 |
MOD_PIKK_1 | 400 | 406 | PF00454 | 0.557 |
MOD_PIKK_1 | 54 | 60 | PF00454 | 0.606 |
MOD_PKA_1 | 338 | 344 | PF00069 | 0.587 |
MOD_PKA_2 | 338 | 344 | PF00069 | 0.642 |
MOD_PKA_2 | 374 | 380 | PF00069 | 0.612 |
MOD_PKA_2 | 411 | 417 | PF00069 | 0.656 |
MOD_PKA_2 | 481 | 487 | PF00069 | 0.420 |
MOD_PKA_2 | 7 | 13 | PF00069 | 0.576 |
MOD_Plk_1 | 307 | 313 | PF00069 | 0.609 |
MOD_Plk_1 | 460 | 466 | PF00069 | 0.436 |
MOD_ProDKin_1 | 147 | 153 | PF00069 | 0.602 |
MOD_ProDKin_1 | 297 | 303 | PF00069 | 0.596 |
MOD_ProDKin_1 | 315 | 321 | PF00069 | 0.703 |
MOD_ProDKin_1 | 390 | 396 | PF00069 | 0.645 |
MOD_ProDKin_1 | 451 | 457 | PF00069 | 0.405 |
MOD_ProDKin_1 | 49 | 55 | PF00069 | 0.379 |
TRG_DiLeu_BaLyEn_6 | 148 | 153 | PF01217 | 0.551 |
TRG_DiLeu_BaLyEn_6 | 214 | 219 | PF01217 | 0.460 |
TRG_ENDOCYTIC_2 | 17 | 20 | PF00928 | 0.470 |
TRG_ENDOCYTIC_2 | 426 | 429 | PF00928 | 0.627 |
TRG_ER_diArg_1 | 248 | 251 | PF00400 | 0.555 |
TRG_ER_diArg_1 | 337 | 340 | PF00400 | 0.601 |
TRG_ER_diArg_1 | 411 | 413 | PF00400 | 0.708 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1IKK4 | Leptomonas seymouri | 59% | 99% |
A0A0S4JPU3 | Bodo saltans | 33% | 95% |
A0A3S7X6B5 | Leishmania donovani | 92% | 100% |
A0A422NYF9 | Trypanosoma rangeli | 43% | 100% |
A4HL40 | Leishmania braziliensis | 77% | 100% |
A4I8M0 | Leishmania infantum | 92% | 100% |
C9ZPU4 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 42% | 98% |
E9B3I1 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 88% | 100% |
V5AUZ3 | Trypanosoma cruzi | 45% | 100% |